ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,064Medicare Part D Prescriptions Filled, Including Refills

Rank: 476 out of 3593

$440K Total Retail Price of All Prescriptions

Rank: 804 out of 3593

730 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 730 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 8,974 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
PRAVASTATIN SODIUM 516 407 1 13
LEVOTHYROXINE SODIUM 483 394 2 4
CARVEDILOL 470 400 3 23
LISINOPRIL 385 331 4 2
OMEPRAZOLE 375 303 5 5
SIMVASTATIN 368 302 6 1
GABAPENTIN 304 209 7 16
AMLODIPINE BESYLATE 283 239 8 3
ALLOPURINOL 267 237 9 35
TRAMADOL HCL 264 207 10 17
ATENOLOL 252 224 11 11
FUROSEMIDE 246 232 12 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 219 194 13 26
LOSARTAN POTASSIUM 216 184 14 14
METFORMIN HCL 185 139 15 6
GLIPIZIDE ER 179 151 16 101
CITALOPRAM HBR 164 131 17 25
NAMENDA 151 151 18 50
BENAZEPRIL HCL 150 123 19 69
LOVASTATIN 144 136 20 20
GLIMEPIRIDE 139 120 21 44
SPIRONOLACTONE 130 112 22 86
RANITIDINE HCL 130 115 22 27
DOXYCYCLINE HYCLATE 125 102 24 141
ISOSORBIDE MONONITRATE ER 123 122 25 61
LOSARTAN-HYDROCHLOROTHIAZIDE 121 82 26 48
NAPROXEN 119 81 27 68
TRIAMTERENE-HCTZ 118 104 28 66
BENAZEPRIL-HYDROCHLOROTHIAZIDE 112 91 29 257
POTASSIUM CHLORIDE 98 92 30 24
INSULIN SYRINGE 93 72 31 91
ATORVASTATIN CALCIUM 91 72 32 15
HYDROCODONE-ACETAMINOPHEN 89 62 S3 33 7
SERTRALINE HCL 89 67 33 28
HUMULIN 70-30 88 53 35 215
CLONIDINE HCL 85 76 36 41
METOPROLOL TARTRATE 84 70 37 8
AMOX TR-POTASSIUM CLAVULANATE 78 63 38 138
ZOLPIDEM TARTRATE 77 32 39 12
WARFARIN SODIUM 72 58 40 18
PEN NEEDLE 72 41 40 188
MELOXICAM 69 48 42 29
FENOFIBRATE 69 58 42 39
ADVAIR DISKUS 69 61 42 47
KLOR-CON 10 68 51 45 114
HYDROCHLOROTHIAZIDE 68 62 45 10
GLIPIZIDE XL 67 62 47 179
BUMETANIDE 64 56 48 148
VENTOLIN HFA 63 49 49 80
PLAVIX 60 53 50 42
LANTUS 60 41 50 57
PREDNISONE 59 40 52 49
METFORMIN HCL ER 57 52 53 67
ALENDRONATE SODIUM 56 47 54 22
DILTIAZEM 24HR CD 55 49 55 173
FINASTERIDE 53 44 56 79
METOPROLOL SUCCINATE 51 37 57 19
CLOPIDOGREL 50 42 58 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.